Sad - Department of Biostatistics OM1 Employee Review

2.0
20 Apr 2023
Recommend
CEO approval
Business outlook

Pros

Before a mass exodus in early 2023 due to senior leadership’s incompetence, this used to be a great place to work: great colleagues, very collaborative and supportive environment, and at times challenging, but interesting work.

Cons

The new senior leadership has had a detrimental impact on the biostatistics group and has created a toxic work environment through their favoritism, lack of understanding of some basic tech processes, lack of self-awareness, leadership skills and real business experience . It's also concerning that the DEI issues have gone south instead of improving with the new chiefs. I don’t feel valued as an employee. It wasn’t always like this and seeing this change has been sad. It’s particularly disheartening to see some women leaders, who like to give speeches about empowering other women in tech and writing blog posts about it, do the exact opposite in real life. Lastly — my personal pet peeve — I appreciated focus on short meetings that allowed me to do my work. With the new leadership — long, frequent, mostly useless meetings and the corporate spiels / gobbledygook are back.

Explore other reviews about OM1

5.0
21 Dec 2024
Anonymous employee
Recommend
CEO approval
Business outlook

Pros

Inspiring to work with very talented and ambitious colleagues. As a company we are really trying to be innovative and be leaders in this space

Cons

Fast paced and turnover seems to be high which makes you need to constantly adapt. I do think that’s just the nature of this industry though

3.0
25 May 2026
Recommend
CEO approval
Business outlook

Pros

The work is meaningful as it focuses on patient outcomes.

Cons

Some of the leadership belittles their people.

1
See reviews by: Helpful|Rating|Date|All